drug

zoliflodacin

Marketedupdated 2mo ago

by Entasis Therapeutics Holdings Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Oct 13, 2029

~3.3 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (6)

Jan 21, 2034compositionUS 8889671
Jan 21, 2034compositionUS 9187495
Jan 21, 2034method-of-use (U-4369)US 9540394
Jan 21, 2034method-of-use (U-4369)US 9839641
Jun 20, 2030compositionUS 86586414.0y
Oct 13, 2029method-of-use (U-4369)US 90405283.3y

FDA exclusivities (2)

Dec 12, 2035GAINGAIN Antibiotic (5y)
Dec 12, 2030NCENew Chemical Entity (5y)4.4y

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 2